News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Brazil Rejects Gilead Sciences, Inc.'s AIDS Drug Patent
September 4, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
RIO DE JANEIRO, Sept 3 (Reuters) - Brazil has rejected a patent request for an AIDS drug made by U.S. firm Gilead, opening the way for cheaper, generic versions to be used in the country's fight against the disease.
Twitter
LinkedIn
Facebook
Email
Print
South America
Gilead Sciences, Inc.
MORE ON THIS TOPIC
Genetown
The Best Way to Answer Salary Interview Questions
June 11, 2024
·
4 min read
·
Lorenzo Soliman
Drug Delivery
Brazil and Caring Cross to Produce Affordable CAR-T, Stem Cell Gene Therapies
March 26, 2024
·
2 min read
·
Tyler Patchen
Drug Development
COVID-19 Brief: Omicron Mutating, Lasting Longer and Killing Faster
January 25, 2022
·
5 min read
·
Mark Terry
Drug Development
Delta Has Been Brutal: How the Deadliest Covid Variant Has Affected the World
October 19, 2021
·
6 min read
·
Mishayl Hanan
